Refractive Errors
Also known as: Farsightedness, Hyperopia, Myopia, Nearsightedness
Methodology & AI Transparency ⓘ
Refractive Errors Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are refractive errors? The cornea and lens of your eye bend (refract) light rays to focus them on the retina.
- 2 Real-world patient consensus: Mapped to Eye Health, Glaucoma & Vision Disorders under ICD-10-CM H52.10 for Refractive Errors clinical workups.
- 3 Typical cash cost range: Workup highlights for Refractive Errors (H52.10): or microsurgical intervention [Refractive Errors H52.10].
- 4 Top reported side effects / signs: Follow-up benchmark in Refractive Errors: maintaining Intraocular Pressure (IOP) [Refractive Errors H52.10] within 10 – 21 mmHg (individualized optic target) (H52.10).
Ask our AI Specialists anything about Refractive Errors
What Is Refractive Errors?
What are refractive errors? The cornea and lens of your eye bend (refract) light rays to focus them on the retina. Refractive errors happen when the shape of your eye prevents light from focusing correctly on the retina. This causes blurry vision. Changes in the eye's shape affect how light rays bend and focus, leading to vision problems. What causes refractive errors? Refractive errors can happen when: The eyeball is too long or too short. The cornea changes shape. The lens becomes less flexible as you age. Each type of refractive error is different, but they all make it hard to see clearly.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Refractive Errors (code H52.10) is impaired trabecular meshwork in Refractive Errors (H52.10: aqueous humor outflow), Cross-referenced with NIH MeSH (Refractive Errors), which Eye Health, Glaucoma & Vision Disorders clinicians address while surveilling Intraocular Pressure (IOP) [Refractive Errors H52.10] (10 – 21 mmHg (individualized optic target) (H52.10)).
Common Symptoms & Clinical Signs
- • The eyeball is too long or too short
- • The cornea changes shape
- • Presentation of Refractive Errors (H52.10): loss of peripheral in Refractive Errors (H52.10: side vision)
- • Secondary Refractive Errors clinical sign: acute eye redness, in Refractive Errors (H52.10: discharge, photophobia, or)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Refractive Errors Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H52.10 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Refractive Errors H52.10] | 10 – 21 mmHg (individualized optic target) (H52.10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Refractive Errors (H52.10: & OCT) | Intact retinal nerve fiber & macula (H52.10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Refractive Errors (H52.10: Blood Pressure) | Microvascular retinal protection (H52.10) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Refractive Errors
Treatment selection for Refractive Errors depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Refractive Errors)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Subretinal Fluid Resolution and Visual Acuity in Patients with Neovascular: What a 1,097-Participant Study Found A greater proportion of ranibizumab-treated eyes with nAMD gained/maintained visual acuity at SRF resolution. Ophthalmology. Retina • 2022-11-15 • Phase III Randomized Trial | N = 1,097 | 90/100 | PMID 35654363 ↗ |
| Can This Approach Help? Inside the Latest Research on Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Although the PDS Q24W effectively maintains vision and retinal stability in most eyes with nAMD,. Ophthalmology. Retina • 2024-12-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 38914294 ↗ |
Refractive Errors Patient Community & “People Like Me” Threads
Filter Refractive Errors community threads and patient logs by age, biological sex, dosage, and treatment duration.